On Demand 2021 Thursday Program

You can earn up to 7.25 AMA PRA Category 1 Credit(s)TM.

Price: FREE for College members who attended the annual meeting, $45 non-members

Allergists are increasingly referred rashes for evaluation and treatment. An integrated allergic and dermatologic approach to eczema, urticaria, contact dermatitis and drug eruptions allow us to extend our practice and lead to better outcome. The allergist is the expert on allergic dermatoses.

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 7.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Target Audience

Medical professionals who treat patients with allergic and/or immunological conditions:

  • Practicing allergist/immunologists
  • Allergy/immunology Fellows-in-Training
  • Physician assistants
  • Nurses and advanced practice nurses
  • Allied health professionals
  • Primary care physicians
  • Other medical professionals

Learning Objectives

Upon completion of this session, participants should be able to:

  • Describe the epidemiologic, clinical and genetic differences in atopic dermatitis patients with skin of color and of various age groups and use these differences to develop an optimal treatment plan
  • Describe current and emerging treatment strategies in managing moderate to severe atopic dermatitis
  • Describe the role of the JAK/STAT pathway in the pathogenesis of atopic dermatitis and to describe the use of JAK inhibitors to manage moderate to severe atopic dermatitis.
  • Implement a shared decision making process to help guide treatment plan development for patients with atopic dermatitis
  • Increase dermatologic rash diagnostic skills.
  • Reference and implement accurate details of updated guidelines.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma & Immunology (ACAAI) policy, the College must identify and resolve conflicts of interest for all individuals responsible for the development, management, presentation, and/ or evaluation relevant to a CME activity. Disclosed information is reviewed in advance in order to manage and resolve any potential conflicts of interest. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.

Specific disclosure information for the 2021 Annual Meeting is available online and via the meeting app.

Course summary
Available credit: 
  • 7.25 AMA PRA Category 1 Credit™
  • 7.25 Attendance
Course opens: 
11/19/2021
Course expires: 
11/18/2024
Cost:
$125.00
Rating: 
0

Ama Alexis, MD

Marcella R. Aquino, MD, FACAAI

Donald V. Belsito, MD

Theresa A. Bingemann, MD, FACAAI

Michael S. Blaiss, MD, FACAAI

Mark Boguniewicz, MD, FACAAI

Timothy J. Craig, DO, FACAAI

Joseph F. Fowler, Jr., MD

Donald Y. Leung, MD, PhD, FACAAI

Kelly M. Maples, MD, FACAAI

Anil Nanda, MD, FACAAI

Karin A. Pacheco, MD, MSPH

Elizabeth J. Phillips, MD

Sarbjit S. Saini, MD

Marc Serota, MD

Ellen R. Sher, MD, FACAAI

Jonathan I. Silverberg, MD, PhD, MPH

Jonathan M. Spergel, MD, PhD, FACAAI

David R. Stukus, MD, FACAAI

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 7.25 AMA PRA Category 1 Credit™
  • 7.25 Attendance

Price

Cost:
$125.00
Please login or create an account to take this course.